Month: August 2021

TORONTO, Aug. 12, 2021 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (Frankfurt:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, announces that its management is not aware of any undisclosed material information relating to the Company that may be contributing to the recent increase in its trading activity. About Revive Therapeutics Ltd. Revive is a life sciences company focused on the research and development of therapeutics for infectious diseases and rare disorders, and it is prioritizing drug development efforts to take advantage of several regulatory incentives awarded by the FDA such as Orphan Drug, Fast Track, Breakthrough Therapy and Rare Pediatric Disease designations. Currently, the...

CHARLOTTE, N.C., Aug. 12, 2021 (GLOBE NEWSWIRE) — LPL Financial LLC (Nasdaq:LPLA) today announced that the team at Tower 68 Financial Advisors, led by founder and CEO Ken South, has launched a new independent practice through affiliation with LPL Financial’s Strategic Wealth Services (SWS) model designed to support the unique needs of breakaway advisors. The team reported having served approximately $550 million in advisory, brokerage and retirement plan assets*. They join LPL from Oppenheimer. South, who spent his teen years as an ocean lifeguard at Tower 68 in Newport Beach, Calif., started his career in the financial services industry in 1985 before founding his solo practice in 2006. He is now joined at Tower 68 Financial Advisors by Chief Operating Officer Steve Arcos and an experienced operational support team. They take...

Bermuda, 12 August 2021 – Avance Gas Holding Ltd (ticker: “AGAS”), will on Thursday 19 August 2021 release its unaudited results for the second quarter of 2021. In connection with the earnings release, an audio webcast and conference call will be held at 15:00 (CEST). The webcast can be accessed at Avance Gas’ website www.avancegas.com. Dial-in details are:+44 (0) 2071 928338 (UK and International), +16467413167 (US) and +47 21563015 (Norway). Please quote the confirmation code 9893329.  Phone lines will open 10 minutes  before the conference call. For further queries, please contact:Randi Navdal Bekkelund, CFO.Tel: +47 22 00 48 29Email: randi.navdal@avancegas.com ABOUT AVANCE GASAvance Gas operates in the global market for transportation of liquefied petroleum gas (LPG). The Company is one of the world’s...

Conference Call and Webcast Today at 4:30 p.m. Eastern Time SAN DIEGO, Aug. 12, 2021 (GLOBE NEWSWIRE) — Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today reported financial results for the quarter ended June 30, 2021 and provided a company update. “This has been, and continues to be, an incredibly productive year for Daré,” said Sabrina Martucci Johnson, President and CEO of Daré Bioscience. “Consistent with our guidance, we submitted our New Drug Application for DARE-BV1, a potential new first-line treatment for bacterial vaginosis, to the FDA in June. Our NDA was accepted for filing and received Priority Review with a PDUFA target date of December 7, 2021. This year we also commenced the Phase 2b RESPOND study of Sildenafil Cream, 3.6%, a potential first-in-category product in development to treat...

MONTREAL, Aug. 12, 2021 (GLOBE NEWSWIRE) — Earth Alive Clean Technologies Inc. (TSXV: EAC) (“Earth Alive” or the “Company”), a Canadian soil health company that develops and manufactures advanced microbial technology products, this morning reported results for the three-month and six month periods ended June 30, 2021. All financial information herein is in Canadian dollars unless otherwise noted. Business HighlightsNewly elected/appointed Board members, Mr. Nikolaos Sofronis and Mrs. Paula Caldwell St-Onge bring extensive business experience and vast international network of contacts to help support the Company’s global growth efforts. Further follow-on US$500,000 purchase order for the ea1TM dust suppressant (“ea1”) announced on June 30, 2021, the fifth consecutive order since November 2018 by this customer for its mine located...

Camsirubicin Phase 1b Clinical Trial Anticipated to Start in the U.S. in Q4 2021Validive® Phase 2b/3 VOICE Trial on Track for Reaching Interim Analysis in H1 2022 WILMETTE, Ill., Aug. 12, 2021 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Monopar or the Company) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company primarily focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients, today announced second quarter 2021 financial results and recent business updates. Recent Business Updates ValidiveMonopar’s Phase 2b/3 VOICE clinical trial of Validive (clonidine HCl mucobuccal tablet) for the prevention of severe oral mucositis (SOM) in patients undergoing chemoradiotherapy (CRT) for oropharyngeal cancer successfully reached its target of 20 activated clinical...

LAS VEGAS, Aug. 12, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Golden Matrix Group, Inc. (OTC: GMGI), a developer and licenser of online gaming platforms, systems and gaming content, today announced it had recorded over $3 million in revenue during its second fiscal quarter ended July 31, 2021. This represents a tripling — or approximate 200% increase — on the $1.05 million in total revenues generated in the comparable year-ago quarter. Additionally, Golden Matrix said it has begun the rollout of its state-of-the-art aggregate gaming system with its first gaming operator in the Asia-Pacific (APAC) region, and with 14 more operators scheduled to be integrated shortly.   The aggregate system, labelled GMX-Ag, will offer a diverse portfolio of gaming products on one single platform that can be integrated seamlessly...

Contract will enable the continued development and eventual construction of the Randolph Solar Park Arizona, Aug. 12, 2021 (GLOBE NEWSWIRE) — EDP Renewables SA (EDPR), through its fully owned subsidiary EDP Renewables North America LLC (EDPR NA), and Salt River Project (SRP) have executed a 25-year power purchase agreement (PPA) for 200 megawatts (MW) at the Randolph Solar Park in Pinal County, located in south-central Arizona. This announcement expands on the communication issued on July 27, 2021.   The 200-MW Randolph Solar Park is expected to be operational in 2023 and will provide economic benefits to the local project communities and state of Arizona by way of payments to local landowners and governments, job opportunities during construction and operations, and an increase in money spent at local businesses in the vicinity...

Continued Company investment across our iPSC platforms, programs, and manufacturingLead program, CNTY-101, remains on track for IND filing in mid-2022Recent IPO with net proceeds of approximately $221MJune 30, 2021 cash, cash equivalents, and marketable securities of $440M PHILADELPHIA, Aug. 12, 2021 (GLOBE NEWSWIRE) — Century Therapeutics, (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology, today reported financial results and business highlights for the second quarter ended June 30, 2021. “With the proceeds raised from our IPO in June, we are well positioned to advance our lead candidate CNTY-101 toward clinical development, targeting IND filing in mid-2022,” said Lalo Flores, Chief Executive Officer, Century Therapeutics. “We continue...